Somewhat Positive News Coverage Somewhat Unlikely to Impact HealthSouth (HLS) Share Price

Media coverage about HealthSouth (NYSE:HLS) has been trending somewhat positive recently, according to Accern Sentiment. The research group identifies negative and positive media coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. HealthSouth earned a media sentiment score of 0.17 on Accern’s scale. Accern also gave news headlines about the company an impact score of 45.8514463880462 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.

HealthSouth (HLS) traded down $0.04 on Wednesday, reaching $49.52. The company’s stock had a trading volume of 290,164 shares, compared to its average volume of 891,888. The company has a quick ratio of 1.34, a current ratio of 1.34 and a debt-to-equity ratio of 1.89. The stock has a market cap of $4,870.00, a PE ratio of 18.07, a price-to-earnings-growth ratio of 1.81 and a beta of 0.55. HealthSouth has a 52 week low of $38.24 and a 52 week high of $50.41.

HealthSouth (NYSE:HLS) last posted its quarterly earnings results on Thursday, October 26th. The company reported $0.66 EPS for the quarter, beating the consensus estimate of $0.65 by $0.01. The company had revenue of $995.60 million during the quarter, compared to analysts’ expectations of $985.75 million. HealthSouth had a return on equity of 23.56% and a net margin of 8.67%. The firm’s revenue was up 7.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.65 EPS. equities research analysts predict that HealthSouth will post 2.72 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, January 16th. Shareholders of record on Tuesday, January 2nd will be issued a $0.25 dividend. This represents a $1.00 annualized dividend and a yield of 2.02%. The ex-dividend date is Friday, December 29th. HealthSouth’s dividend payout ratio (DPR) is 36.50%.

Several brokerages recently weighed in on HLS. Stephens began coverage on shares of HealthSouth in a research note on Thursday, August 31st. They issued an “overweight” rating and a $53.00 target price for the company. William Blair reissued an “outperform” rating on shares of HealthSouth in a research note on Tuesday, November 21st. SunTrust Banks set a $58.00 target price on shares of HealthSouth and gave the company a “buy” rating in a research note on Thursday, December 21st. Robert W. Baird reissued a “buy” rating and issued a $55.00 target price on shares of HealthSouth in a research note on Monday, October 9th. Finally, Piper Jaffray Companies reissued a “hold” rating and issued a $50.00 target price on shares of HealthSouth in a research note on Sunday, September 17th. Two analysts have rated the stock with a sell rating, four have assigned a hold rating and seven have issued a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $52.44.

In other news, Director Yvonne M. Curl bought 1,000 shares of the firm’s stock in a transaction dated Wednesday, November 1st. The stock was acquired at an average price of $45.95 per share, for a total transaction of $45,950.00. Following the acquisition, the director now owns 64,144 shares of the company’s stock, valued at $2,947,416.80. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. 1.60% of the stock is owned by insiders.

ILLEGAL ACTIVITY NOTICE: “Somewhat Positive News Coverage Somewhat Unlikely to Impact HealthSouth (HLS) Share Price” was published by Community Financial News and is the property of of Community Financial News. If you are viewing this piece of content on another domain, it was illegally copied and reposted in violation of U.S. & international trademark & copyright law. The original version of this piece of content can be accessed at

About HealthSouth

HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice.

Insider Buying and Selling by Quarter for HealthSouth (NYSE:HLS)

Receive News & Ratings for HealthSouth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth and related companies with's FREE daily email newsletter.


Leave a Reply

share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit